Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fabian Weipert
Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
Related publications
Anti-Gd2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells
Pharmaceutical Research
Organic Chemistry
Biotechnology
Molecular Medicine
Pharmacology
Pharmaceutical Science
Establishment of Drug-Resistant Cell Lines as a Model in Experimental Oncology: A Review
Anticancer Research
Medicine
Cancer Research
Oncology
YM155 Reverses Statin Resistance in Renal Cancer by Reducing Expression of Survivin
Anticancer Research
Medicine
Cancer Research
Oncology
Survivin Selective Inhibitor YM155 Promotes Cisplatin‑induced Apoptosis in Embryonal Rhabdomyosarcoma
International Journal of Oncology
Cancer Research
Oncology
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Monoclonal Antibody Detecting Cell Surface Epitope on Some Drug Resistant Human Tumour Cell Lines
British Journal of Cancer
Cancer Research
Oncology
Molecular Characterisation of Isogenic Taxane Resistant Cell Lines Identify Novel Drivers of Drug Resistance
BMC Cancer
Cancer Research
Oncology
Genetics
TP53BP2 Decreases Cell Proliferation and Induces Autophagy in Neuroblastoma Cell Lines
Oncology Letters
Cancer Research
Oncology
Design of a Large-Scale Femtoliter Droplet Array for Single-Cell Analysis of Drug-Tolerant and Drug-Resistant Bacteria
Frontiers in Microbiology
Microbiology
